傳恆大物業(06666.HK)向合生創展(00754.HK)轉讓控股權獲聯交所同意(更正)
《財聯社》引述消息報道,合生創展(00754.HK)擬收購恆大物業(06666.HK)約51%股份,以獲取後者的控股權,估值超過400億元。
消息指出,恆大物業上市不到一年,如要出售控股權,需要香港聯交所同意,而是次轉讓控股權是經過聯交所同意。
根據聯交所主板上市規則規定,控股股東自交易日起六個月內不得以任何方式處置所持公司股票,自前述六個月屆滿之日起六個月內,不得喪失控制權。
(更正:2021-10-04 13:57:51傳恆大物業(06666.HK)向合生創展(00754.HK)轉讓控股權獲聯交所同意)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.